Latest Commercialization News

Imugene has secured FDA backing to advance its allogeneic CAR T therapy, azer-cel, into a pivotal Phase 3 trial targeting difficult-to-treat diffuse large B-cell lymphoma (DLBCL), including patients relapsed after prior CAR-T treatment.

Chimeric Therapeutics has won FDA Orphan Drug Designation for its CHM CDH17 CAR-T therapy targeting gastric cancer, advancing its clinical development with regulatory incentives and potential market exclusivity.

Telix Pharmaceuticals has dosed the first patient in the randomized expansion phase of its pivotal ProstACT Global Phase 3 trial for TLX591, targeting advanced prostate cancer. The trial is expanding globally, with regulatory submissions underway in the US and Europe.

Lincoln Minerals has partnered with Revera Energy to explore a green hydrogen-fueled iron pellet plant at the Eyre Magnetite Project, aiming to advance sustainable steel production in South Australia.

Mandrake Resources has inked a binding agreement with DISA Technologies to recover uranium and critical minerals from abandoned mine waste across its expansive Utah Project, tapping into a growing US government-backed market.

NH3 Clean Energy has signed a pivotal Memorandum of Understanding with Japan’s ITOCHU Corporation to develop clean ammonia bunkering operations in Western Australia’s Pilbara region and across the Asia Pacific by 2030.

Audeara Limited has secured its largest-ever Australian wholesale purchase order worth $560,000, driving year-to-date wholesale revenues to $1.75 million and matching full FY25 figures. The company is also expanding manufacturing into China, signaling growing international ambitions.

Ardea Resources updates its Definitive Feasibility Study for the Kalgoorlie Nickel Project, confirming a streamlined processing approach and a new sale product that could enhance project economics and market reach.

Anson Resources' subsidiary A1 Lithium has signed a non-binding MoU with Nusano to supply high-purity lithium chloride from Utah’s Green River project for advanced nuclear isotope production. This marks a strategic step into the nuclear technology supply chain alongside ongoing electric vehicle market efforts.

TZ Limited has successfully raised $750,000 through a placement, boosted by strong shareholder support, while advancing key contracts with Microsoft and planning significant debt reduction.

Sparc Hydrogen has reached a pivotal milestone with sustained hydrogen generation at its Roseworthy pilot plant, advancing its innovative photocatalytic water splitting technology towards commercialisation.

DorsaVi reports significant progress in its resistive RAM (RRAM) development, optimizing memory technology for integration with neuromorphic computing at the 22nm technology node. This advancement positions the company to deliver energy-efficient edge-AI solutions for wearables, robotics, and industrial safety.